Search research articles
Contact Us
Filters
Showing results (201-210 of 208) with videos related to
Page
of 21
Sort By:
You have reached the last page of results.
This site can display upto 208 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 24, 1999
[Efficacy and side effect of continuous intra-arterial infusion of high-dose 5-FU for liver metastases of colorectal cancer]
Y Kurokawa, Y Hasuike, T Hattori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 11, 2011
Cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer: results from the randomised phase II part of a phase I/II study
T Kato, K Muro, K Yamaguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 1, 1996
Strategy for breast conserving treatment--analysis of recurrence and prognosis after breast cosnserving treatment
E Shin, Y Takatsuka, Y Okamura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 15, 1998
[Efficacy of combination therapy (hepatectomy and prophylactic arterial chemoinfusion) for liver metastases of colorectal cancer]
Y Hasuike, T Hattori, I Nishishou, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 16, 2006
Expression and mutation of SMAD4 in poorly differentiated carcinoma and signet-ring cell carcinoma of the colorectum
I Seshimo, H Yamamoto, H Mishima, et al.
International Journal of Cancer
|
February 13, 1999
Molecular characteristics of poorly differentiated adenocarcinoma and signet-ring-cell carcinoma of colorectum
Y Kawabata, N Tomita, T Monden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 25, 2015
FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study
S Iwamoto, T Takahashi, H Tamagawa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 25, 2019
SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer
Y Munemoto, M Nakamura, M Takahashi, et al.
Page
of 21
Search research articles
Search
Showing results (201-210 of 208) with videos related to
Sort By:
Page
of 21
You have reached the last page of results.
This site can display upto 208 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 24, 1999
[Efficacy and side effect of continuous intra-arterial infusion of high-dose 5-FU for liver metastases of colorectal cancer]
Y Kurokawa, Y Hasuike, T Hattori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 11, 2011
Cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer: results from the randomised phase II part of a phase I/II study
T Kato, K Muro, K Yamaguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 1, 1996
Strategy for breast conserving treatment--analysis of recurrence and prognosis after breast cosnserving treatment
E Shin, Y Takatsuka, Y Okamura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 15, 1998
[Efficacy of combination therapy (hepatectomy and prophylactic arterial chemoinfusion) for liver metastases of colorectal cancer]
Y Hasuike, T Hattori, I Nishishou, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 16, 2006
Expression and mutation of SMAD4 in poorly differentiated carcinoma and signet-ring cell carcinoma of the colorectum
I Seshimo, H Yamamoto, H Mishima, et al.
International Journal of Cancer
|
February 13, 1999
Molecular characteristics of poorly differentiated adenocarcinoma and signet-ring-cell carcinoma of colorectum
Y Kawabata, N Tomita, T Monden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 25, 2015
FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study
S Iwamoto, T Takahashi, H Tamagawa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 25, 2019
SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer
Y Munemoto, M Nakamura, M Takahashi, et al.
Page
of 21